Almac and Middlebrook Pharmaceuticals discuss their successful partnership in Tablets and Capsules

Almac and Middlebrook Pharmaceuticals, Inc. discuss their partnership in the May edition of Tablets and Capsules. Within the article, Don Treacy (Snr VP of Development and Manufacturing Operations, Middlebrook) discusses the development of the first and only, once-daily amoxicillin treatment, Moxatag, and the steps involved in developing a successful, strategic partnership with Almac to ensure a successful launch of Moxatag.